Abstract: This disclosure relates to modified guide RNAs comprising an internal linker for in vitro and in vivo gene editing methods.

Abstract: Provided is a method for administering to a subject, via an implantable delivery device, a continuous subcutaneous dose of glucagon-like peptide-1 (GLP-1) analog, where the subject is orally co-administered a drug after implantation of the implantable delivery device and during continuous subcutaneous dosing of the GLP-1 analog.

Abstract: Systems and methods are provided for configuring automatic playback settings on a media playback device. A graphical user interface displays automatic playback settings and receives selections of customized settings for automatic playback. The settings can include context granularity for automatic playback, limiting autoplay to when the media playback device is connected to a wireless network, and activating an audible notification when automatic playback of media content is beginning. An initial queue of media content is selected for playback on the media playback device. The system ascertains whether autoplay is enabled for a particular situation. If autoplay is enabled, the system automatically generates a queue of media that is related to the initial queue and initiates playback on the media playback device after the initial queue concludes.

Abstract: A data processing system maintaining a plurality of masking engines is configured to synchronize masking jobs between different masking engines, in order to ensure consistent outputs between the different engines for the same job. Upon identifying a masking job object maintained by a first masking engine to be exported, dependencies of the job object are traversed to identify all objects depended on by the job object, which are used to form an export payload. At least object of the payload is a reference object that references other objects maintained by the first masking engine. When importing the export payload onto a second masking engine, the export payload is analyzed to identify revision information of the referenced object. The identified revision information is compared with revision information of a corresponding object maintained by the second masking engine, and the referenced objects is imported based upon a result of the comparison.

Abstract: A process is provided for upgrading a renewable feedstock. The process includes introducing the renewable feedstock into a fluid catalytic cracking (FCC) reactor unit operating under catalytic cracking conditions and comprising a circulating inventory of an equilibrium catalyst composition; removing a portion of the equilibrium catalyst inventory from the FCC reactor unit while replacing all the equilibrium catalyst removed from the unit with a spent catalyst to obtain a composite circulating catalyst within the FCC reactor unit; and contacting the composite circulating catalyst with the renewable feedstock in the FCC reactor unit under a steady state environment to provide a product stream comprising cracked products.

Abstract: Methods and systems of completing tracking-based transactions are disclosed. A financial institution computing system includes a customer database retrievably storing information relating to a plurality of financial accounts, a tag database retrievably storing information relating to a plurality of tags, a network interface circuit, and a transaction circuit. The transaction circuit receives a transaction request with at least one tag relating to an order of goods from a seller computing system. A transaction schedule is generated based on the transaction request and customer information in the customer database, and is stored in the tag database. The transaction circuit receives tag data corresponding to physical movement of the order of goods and performs at least one transaction pursuant to the transaction schedule based on received tag data.

Abstract: A data processing system maintaining a plurality of masking engines is configured to synchronize masking jobs between different masking engines, in order to ensure consistent outputs between the different engines for the same job. Upon identifying a masking job object maintained by a first masking engine to be exported, dependencies of the job object are traversed to identify all objects depended on by the job object, which are used to form an export payload. At least object of the payload is a reference object that references other objects maintained by the first masking engine. When importing the export payload onto a second masking engine, the export payload is analyzed to identify revision information of the referenced object. The identified revision information is compared with revision information of a corresponding object maintained by the second masking engine, and the referenced objects is imported based upon a result of the comparison.

Abstract: The present invention provides an improved method for solvent liquefaction of biomass to produce liquid products such as transportation fuel. The method uses a novel solvent combination that promotes liquefaction relatively quickly, and it reduces the need to transport large amounts of hydrogen or hydrogen-carrying solvents. It operates at lower pressure than previous methods, does not require a catalyst or hydrogen gas or CO input, and provides very high conversion of biomass into a bio-oil that can be further processed in a petroleum refinery. It also beneficially provides a way to recycle a portion of the crude liquefaction product for use as part of the solvent combination for the biomass liquefaction reaction.

Abstract: A tissue opening occluder comprising first and second occluder portions, each occluder portion including a frame structure and an attachment structure to attach one portion to the other portion. The frames may be utilized to constrain the tissue between the two portions enough to restrict the significant passage of blood therethrough. The frame portions may be covered by a fabric suspended from a perimeter thereof. The occluder portions are conjoined at least one point on each portion.

Abstract: A tissue opening occluder comprising first and second occluder portions, each occluder portion including a frame structure and an attachment structure to attach one portion to the other portion. The frames may be utilized to constrain the tissue between the two portions enough to restrict the significant passage of blood therethrough. The frame portions may be covered by a fabric suspended from a perimeter thereof. The occluder portions are conjoined at least one point on each portion.

Abstract: A tissue opening occluder comprising first and second occluder portions, each occluder portion including a frame structure and an attachment structure to attach one portion to the other portion. The frames may be utilized to constrain the tissue between the two portions enough to restrict the significant passage of blood therethrough. The frame portions may be covered by a fabric suspended from a perimeter thereof. The occluder portions are conjoined at least one point on each portion.

Abstract: The present invention provides 1,4 substituted piperazines, 1,4 substituted piperidines, and 1-substituted, 4-alkylidenyl piperidines compounds. The compounds of the invention are dual acting molecules having both leukotriene inhibition properties as well as antihistaminergic properties. The compounds of the invention are useful for treating conditions in which there is likely to be a histamine and/or leukotriene component. These conditions include preferably asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, rheumatoid arthritis, inflammatory bowel disease, chronic obsructive pulmonary disease, thrombotic disease and otitis media. Also provided are methods of treating asthma and rhinitis by administering an effective asthma and rhinitis-relieving amount of the compounds to a subject in need thereof.

Abstract: The present invention provides 1,4 substituted piperazines, 1,4 substituted piperidines, and 1-substituted, 4-alkylidenyl piperidines compounds. The compounds of the invention are dual acting molecules having both leukotriene inhibition properties as well as antihistaminergic properties. The compounds of the invention are useful for treating conditions in which there is likely to be a histamine and/or leukotriene component. These conditions include preferably asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, rheumatoid arthritis, inflammatory bowel disease, chronic obstructive pulmonary disease, thrombotic disease and otitis media. Also provided are methods of treating asthma and rhinitis by administering an effective asthma and rhinitis-relieving amount of the compounds to a subject in need thereof.

Abstract: The present invention provides 1,4 substituted piperazines, 1,4 substituted piperidines, and 1-substituted,4-alkylidenyl piperidines compounds. The compounds of the invention are dual acting molecules having both leukotriene inhibition properties as well as antihistaminergic properties. The compounds of the invention are useful for treating conditions in which there is likely to be a histamine and/or leukotriene component. These conditions include preferably asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, rheumatoid arthritis, inflammatory bowel disease, chronic obstructive pulmonary disease, thrombotic disease and otitis media. Also provided are methods of treating asthma and rhinitis by administering an effective asthma and rhinitis-relieving amount of the compounds to a subject in need thereof.

Abstract: The present invention provides 1,4 substituted piperazines, 1,4 substituted piperidines, and 1-substituted,4-alkylidenyl piperidines compounds. The compounds of the invention are dual acting molecules having both leukotriene inhibition properties as well as antihistaminergic properties. The compounds of the invention are useful for treating conditions in which there is likely to be a histamine and/or leukotriene component. These conditions include preferably asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, rheumatoid arthritis, inflammatory bowel disease, chronic obstructive pulmonary disease, thrombotic disease and otitis media. Also provided are methods of treating asthma and rhinitis by administering an effective asthma and rhinitis-relieving amount of the compounds to a subject in need thereof.

Abstract: The present invention provides substituted benzofuran, indene, thianaphthene and oxidized thianaphthene compounds and methods of treatment and pharmaceutical compositions that comprise such compounds. Preferred compounds of the invention contain benzofuran, indene or thianaphthene group substituted with a tetrahydrofuran or other alicyclic group.

Abstract: A heavy hydrocarbon is rendered pipelineable by hydroconverting the heavy hydrocarbon under conditions sufficient to obtain a product oil of lowered viscosity and an API gravity suitable for pipelining and thereafter adding a diluent modified hydrocarbon to the product oil in an amount sufficient to stabilize the product oil against asphaltene phase separation and when phase separated asphaltene is present to dissolve the phase separated asphaltenes.